Table of Content

1 Flu (Influenza) Vaccine Market Overview
1.1 Product Overview and Scope of Flu (Influenza) Vaccine
1.2 Flu (Influenza) Vaccine Segment by Type
1.2.1 Global Flu (Influenza) Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Split Influenza Vaccine
1.2.3 Pandemic Influenza Vaccine
1.2.4 Subunit Influenza Vaccine
1.2.5 Quadrivalent Influenza Vaccine
1.3 Flu (Influenza) Vaccine Segment by Application
1.3.1 Flu (Influenza) Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Flu (Influenza) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Flu (Influenza) Vaccine Revenue 2016-2027
1.4.2 Global Flu (Influenza) Vaccine Sales 2016-2027
1.4.3 Flu (Influenza) Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Flu (Influenza) Vaccine Market Competition by Manufacturers
2.1 Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Flu (Influenza) Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Flu (Influenza) Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Flu (Influenza) Vaccine Market Competitive Situation and Trends
2.5.1 Flu (Influenza) Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Flu (Influenza) Vaccine Players Market Share by Revenue
2.5.3 Global Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Flu (Influenza) Vaccine Retrospective Market Scenario by Region
3.1 Global Flu (Influenza) Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Flu (Influenza) Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Flu (Influenza) Vaccine Market Facts & Figures by Country
3.3.1 North America Flu (Influenza) Vaccine Sales by Country
3.3.2 North America Flu (Influenza) Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Flu (Influenza) Vaccine Market Facts & Figures by Country
3.4.1 Europe Flu (Influenza) Vaccine Sales by Country
3.4.2 Europe Flu (Influenza) Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Flu (Influenza) Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Flu (Influenza) Vaccine Sales by Region
3.5.2 Asia Pacific Flu (Influenza) Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Flu (Influenza) Vaccine Market Facts & Figures by Country
3.6.1 Latin America Flu (Influenza) Vaccine Sales by Country
3.6.2 Latin America Flu (Influenza) Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Flu (Influenza) Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Country
3.7.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Flu (Influenza) Vaccine Historic Market Analysis by Type
4.1 Global Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Flu (Influenza) Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Flu (Influenza) Vaccine Price by Type (2016-2021)

5 Global Flu (Influenza) Vaccine Historic Market Analysis by Application
5.1 Global Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Flu (Influenza) Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hualan Bio
6.1.1 Hualan Bio Corporation Information
6.1.2 Hualan Bio Description and Business Overview
6.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hualan Bio Product Portfolio
6.1.5 Hualan Bio Recent Developments/Updates
6.2 CCBIO
6.2.1 CCBIO Corporation Information
6.2.2 CCBIO Description and Business Overview
6.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CCBIO Product Portfolio
6.2.5 CCBIO Recent Developments/Updates
6.3 Aleph Biomedical
6.3.1 Aleph Biomedical Corporation Information
6.3.2 Aleph Biomedical Description and Business Overview
6.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aleph Biomedical Product Portfolio
6.3.5 Aleph Biomedical Recent Developments/Updates
6.4 SANOFI
6.4.1 SANOFI Corporation Information
6.4.2 SANOFI Description and Business Overview
6.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SANOFI Product Portfolio
6.4.5 SANOFI Recent Developments/Updates
6.5 Adimmune
6.5.1 Adimmune Corporation Information
6.5.2 Adimmune Description and Business Overview
6.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Adimmune Product Portfolio
6.5.5 Adimmune Recent Developments/Updates
6.6 ZYAK
6.6.1 ZYAK Corporation Information
6.6.2 ZYAK Description and Business Overview
6.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 ZYAK Product Portfolio
6.6.5 ZYAK Recent Developments/Updates
6.7 SINOVAC
6.6.1 SINOVAC Corporation Information
6.6.2 SINOVAC Description and Business Overview
6.6.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SINOVAC Product Portfolio
6.7.5 SINOVAC Recent Developments/Updates
6.8 Changsheng Biological
6.8.1 Changsheng Biological Corporation Information
6.8.2 Changsheng Biological Description and Business Overview
6.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Changsheng Biological Product Portfolio
6.8.5 Changsheng Biological Recent Developments/Updates
6.9 SIOBP
6.9.1 SIOBP Corporation Information
6.9.2 SIOBP Description and Business Overview
6.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 SIOBP Product Portfolio
6.9.5 SIOBP Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GSK Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Aimei Hissen
6.11.1 Aimei Hissen Corporation Information
6.11.2 Aimei Hissen Flu (Influenza) Vaccine Description and Business Overview
6.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Aimei Hissen Product Portfolio
6.11.5 Aimei Hissen Recent Developments/Updates
6.12 Tianyuan Bio-pharma(Novartis)
6.12.1 Tianyuan Bio-pharma(Novartis) Corporation Information
6.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Description and Business Overview
6.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Tianyuan Bio-pharma(Novartis) Product Portfolio
6.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
6.13 Simcere Vaxtec
6.13.1 Simcere Vaxtec Corporation Information
6.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Description and Business Overview
6.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Simcere Vaxtec Product Portfolio
6.13.5 Simcere Vaxtec Recent Developments/Updates

7 Flu (Influenza) Vaccine Manufacturing Cost Analysis
7.1 Flu (Influenza) Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Flu (Influenza) Vaccine
7.4 Flu (Influenza) Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Flu (Influenza) Vaccine Distributors List
8.3 Flu (Influenza) Vaccine Customers

9 Flu (Influenza) Vaccine Market Dynamics
9.1 Flu (Influenza) Vaccine Industry Trends
9.2 Flu (Influenza) Vaccine Growth Drivers
9.3 Flu (Influenza) Vaccine Market Challenges
9.4 Flu (Influenza) Vaccine Market Restraints

10 Global Market Forecast
10.1 Flu (Influenza) Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Flu (Influenza) Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Flu (Influenza) Vaccine by Type (2022-2027)
10.2 Flu (Influenza) Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Flu (Influenza) Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Flu (Influenza) Vaccine by Application (2022-2027)
10.3 Flu (Influenza) Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Flu (Influenza) Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Flu (Influenza) Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Flu (Influenza) Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Flu (Influenza) Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Flu (Influenza) Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Flu (Influenza) Vaccine Covered in This Study
Table 5. Global Flu (Influenza) Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Flu (Influenza) Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Flu (Influenza) Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Flu (Influenza) Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Flu (Influenza) Vaccine Product Type
Table 12. Global Flu (Influenza) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Flu (Influenza) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu (Influenza) Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Flu (Influenza) Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Flu (Influenza) Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Flu (Influenza) Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Flu (Influenza) Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Flu (Influenza) Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Flu (Influenza) Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Flu (Influenza) Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Flu (Influenza) Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Flu (Influenza) Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Flu (Influenza) Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Flu (Influenza) Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Flu (Influenza) Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Flu (Influenza) Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Flu (Influenza) Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Flu (Influenza) Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Flu (Influenza) Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Flu (Influenza) Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Flu (Influenza) Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Flu (Influenza) Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Flu (Influenza) Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Flu (Influenza) Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Flu (Influenza) Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Flu (Influenza) Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Flu (Influenza) Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Flu (Influenza) Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Hualan Bio Corporation Information
Table 49. Hualan Bio Description and Business Overview
Table 50. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Hualan Bio Flu (Influenza) Vaccine Product
Table 52. Hualan Bio Recent Developments/Updates
Table 53. CCBIO Corporation Information
Table 54. CCBIO Description and Business Overview
Table 55. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. CCBIO Flu (Influenza) Vaccine Product
Table 57. CCBIO Recent Developments/Updates
Table 58. Aleph Biomedical Corporation Information
Table 59. Aleph Biomedical Description and Business Overview
Table 60. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Aleph Biomedical Flu (Influenza) Vaccine Product
Table 62. Aleph Biomedical Recent Developments/Updates
Table 63. SANOFI Corporation Information
Table 64. SANOFI Description and Business Overview
Table 65. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. SANOFI Flu (Influenza) Vaccine Product
Table 67. SANOFI Recent Developments/Updates
Table 68. Adimmune Corporation Information
Table 69. Adimmune Description and Business Overview
Table 70. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Adimmune Flu (Influenza) Vaccine Product
Table 72. Adimmune Recent Developments/Updates
Table 73. ZYAK Corporation Information
Table 74. ZYAK Description and Business Overview
Table 75. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. ZYAK Flu (Influenza) Vaccine Product
Table 77. ZYAK Recent Developments/Updates
Table 78. SINOVAC Corporation Information
Table 79. SINOVAC Description and Business Overview
Table 80. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. SINOVAC Flu (Influenza) Vaccine Product
Table 82. SINOVAC Recent Developments/Updates
Table 83. Changsheng Biological Corporation Information
Table 84. Changsheng Biological Description and Business Overview
Table 85. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Changsheng Biological Flu (Influenza) Vaccine Product
Table 87. Changsheng Biological Recent Developments/Updates
Table 88. SIOBP Corporation Information
Table 89. SIOBP Description and Business Overview
Table 90. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. SIOBP Flu (Influenza) Vaccine Product
Table 92. SIOBP Recent Developments/Updates
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. GSK Flu (Influenza) Vaccine Product
Table 97. GSK Recent Developments/Updates
Table 98. Aimei Hissen Corporation Information
Table 99. Aimei Hissen Description and Business Overview
Table 100. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Aimei Hissen Flu (Influenza) Vaccine Product
Table 102. Aimei Hissen Recent Developments/Updates
Table 103. Tianyuan Bio-pharma(Novartis) Corporation Information
Table 104. Tianyuan Bio-pharma(Novartis) Description and Business Overview
Table 105. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product
Table 107. Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
Table 108. Simcere Vaxtec Corporation Information
Table 109. Simcere Vaxtec Description and Business Overview
Table 110. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Simcere Vaxtec Flu (Influenza) Vaccine Product
Table 112. Simcere Vaxtec Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Flu (Influenza) Vaccine Distributors List
Table 116. Flu (Influenza) Vaccine Customers List
Table 117. Flu (Influenza) Vaccine Market Trends
Table 118. Flu (Influenza) Vaccine Growth Drivers
Table 119. Flu (Influenza) Vaccine Market Restraints
Table 120. Global Flu (Influenza) Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 121. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Flu (Influenza) Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Flu (Influenza) Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 125. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Flu (Influenza) Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Flu (Influenza) Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 129. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Flu (Influenza) Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Flu (Influenza) Vaccine
Figure 2. Global Flu (Influenza) Vaccine Market Share by Type in 2020 & 2027
Figure 3. Split Influenza Vaccine Product Picture
Figure 4. Pandemic Influenza Vaccine Product Picture
Figure 5. Subunit Influenza Vaccine Product Picture
Figure 6. Quadrivalent Influenza Vaccine Product Picture
Figure 7. Global Flu (Influenza) Vaccine Market Share by Application in 2020 & 2027
Figure 8. For Children (6 months to 3 years)
Figure 9. For Adults and Children over 3 years
Figure 10. Global Flu (Influenza) Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Flu (Influenza) Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Flu (Influenza) Vaccine Sales 2016-2027 (K Units)
Figure 13. Global Flu (Influenza) Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Flu (Influenza) Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Flu (Influenza) Vaccine Players: Market Share by Revenue in 2020
Figure 17. Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Flu (Influenza) Vaccine Sales Market Share by Region (2016-2021)
Figure 19. Global Flu (Influenza) Vaccine Sales Market Share by Region in 2020
Figure 20. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2016-2021)
Figure 21. Global Flu (Influenza) Vaccine Revenue Market Share by Region in 2020
Figure 22. U.S. Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Flu (Influenza) Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Flu (Influenza) Vaccine by Type (2016-2021)
Figure 47. Sales Market Share of Flu (Influenza) Vaccine by Application (2016-2021)
Figure 48. Sales Market Share of Flu (Influenza) Vaccine by Application in 2020
Figure 49. Revenue Share of Flu (Influenza) Vaccine by Application (2016-2021)
Figure 50. Revenue Share of Flu (Influenza) Vaccine by Application in 2020
Figure 51. Manufacturing Cost Structure of Flu (Influenza) Vaccine
Figure 52. Manufacturing Process Analysis of Flu (Influenza) Vaccine
Figure 53. Flu (Influenza) Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed